Skip to main content
Clinical Trials/NCT02894229
NCT02894229UnknownNot Applicable

The Mindfulness Intervention and Repeated Acute Stress (MIRAS) Study

Ohio University0 sites150 target enrollmentStarted: August 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
150
Primary Endpoint
Perceived Stress Scale

Study Overview

Brief Summary

The primary purpose of the present study is to investigate the relationship between mindfulness and stress habituation. The investigators propose to measure the effect of mindfulness on stress habituation by randomly assigning participants to a 6-week mindfulness-based stress reduction group intervention, a cognitive-behavioral skills group comparison intervention, or a waitlist control condition followed by repeated acute psychosocial stress testing (2 laboratory sessions on 2 separate days). Saliva will be collected from participants throughout both laboratory testing sessions to measure HPA axis activation (an essential stress-responsive system), along with other measures of physiological and psychological stress (e.g., heart rate, blood pressure, emotions). Mediators and moderators of treatment outcome will be examined. The cognitive-behavioral skills group condition is an appropriate comparison group due to the well-documented efficacy of cognitive-behavioral interventions on stress.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •English-speaking adults who are between the ages of 18-50, who are in general good health
  • •Perceived stress scores (PSS) > 3 on a screening survey

Exclusion Criteria

  • •reported previous completion of a Mindfulness-Based Stress Reduction or Cognitive Behavioral Therapy program.
  • •reported pregnancy
  • •reported use of steroid medication
  • •presence of a major psychiatric or endocrine disorder (e.g., Major Depression, Cushings Disease; self-reported)
  • •reported regular wake time after 10:00 AM on a weekday

Arms & Interventions

No intervention wait-list

No Intervention

This arm will receive no intervention for approximately the first 4 months. At the conclusion of the 4-month period, this group will receive a 6-week cognitive-behavioral therapy (CBT) group

Mindfulness Based Stress Reduction(MBSR)

Active Comparator

This arm will receive 6 weekly, 2-hour groups that focuses on mindfulness meditation for stress reduction

Intervention: Mindfulness Based Stress Reduction (Behavioral)

Cognitive Behavioral Therapy (CBT) Group

Active Comparator

This are will receive 6 weekly, 2-hour groups that focus on cognitive-behavioral skills for stress

Intervention: Cognitive-Behavioral Therapy (CBT) Group (Behavioral)

Outcomes

Primary Outcomes

Perceived Stress Scale

Time Frame: Baseline and 6-weeks after baseline.

A 10-item self-report measure that examines perceived stress. The measure produces one total score. The investigators will measure the change in total score from baseline to the 6-week assessment.

Salivary cortisol response to repeated acute psychosocial stress

Time Frame: Post-intervention (approximately 7-14 weeks after baseline assessment)

4 saliva samples will be collected before and after a psychosocial stressor task, which will be administered on two separate occasions separated in time by at least 48 hours. All saliva samples will be assayed for salivary cortisol using enzyme-linked immunoassays. The investigators will measure the change in cortisol stress profiles from the first stressor exposure to the second.

Secondary Outcomes

  • State Affect(Post-intervention (approximately 7-14 weeks after baseline assessment))
  • State mindfulness(Post-intervention (approximately 7-14 weeks after baseline assessment))
  • Implicit association between self and shame(Post-intervention (approximately 7-14 weeks after baseline assessment))
  • State rumination(Post-intervention (approximately 7-14 weeks after baseline assessment))
  • Stress appraisals(Post-intervention (approximately 7-14 weeks after baseline assessment))
  • Sleep(Baseline and 6-weeks)
  • Equanimity(Baseline and 6-weeks)
  • Smoking(Baseline and 6-weeks)
  • Alcohol(Baseline and 6-weeks)
  • Marijuana(Baseline and 6-weeks)
  • Perceived control over thoughts(Baseline and 6 weeks)
  • Coping Skills(Baseline and 6-weeks)
  • Cardiovascular response to repeated acute psychosocial stress(Post-intervention (approximately 7-14 weeks after baseline assessment))
  • Autonomic response to repeated acute psychosocial stress(Post-intervention (approximately 7-14 weeks after baseline assessment))
  • Dispositional Mindfulness(Baseline and 6-weeks)
  • Depressed mood(Baseline and 6-weeks)
  • Anxiety(Baseline and 6-weeks later)
  • Social Connectedness(Baseline and 6-weeks)
  • Optimism(Baseline and 6-weeks)
  • Worry(Baseline and 6-weeks)
  • Experiential Avoidance(Baseline and 6-weeks)
  • Emotion Regulation(Baseline and 6-weeks)
  • Negative Urgency(Baseline and 6-weeks)
  • Chronic Stress(Baseline and 6-weeks)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials